Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference [Yahoo! Finance]
Carlsmed, Inc. (CARL)
Company Research
Source: Yahoo! Finance
and sterile single-use instruments across the pre/intra/post-op workflow; the company has expanded into cervical cases and cut order-to-delivery times from about eight weeks to six days. Financial outlook : Carlsmed generated $50.5M in revenue in its first public year (Q4 “north of $15M” and a 76.5% gross margin) and guided to $70M–$75.5M for 2025 (˜44% growth at the midpoint) with IPO proceeds providing runway toward cash-flow breakeven. Clinical and reimbursement advantages : Two-year data published in the Global Spine Journal showed a 74% reduction in revision rates versus traditional stock devices, and the company has FDA Breakthrough Device designations plus NTAP and permanent DRG reimbursements that provide significant incremental hospital payments (including an NTAP for cervical procedures reported as “north of $21,000”). Interested in Carlsmed, Inc.? Here are five stocks we like better. Carlsmed (NASDAQ:CARL) used its presentation at Canaccord Genuity's Musculoskeletal
Show less
Read more
Impact Snapshot
Event Time:
CARL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARL alerts
High impacting Carlsmed, Inc. news events
Weekly update
A roundup of the hottest topics
CARL
News
- Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M [Seeking Alpha]Seeking Alpha
- Carlsmed Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire
CARL
Earnings
- 2/25/26 - Beat
CARL
Sec Filings
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- 2/25/26 - Form S-8
- CARL's page on the SEC website